<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://humplebystrauss.com/news/mesothelioma-treatment-access-specialist-referrals-november-2026</loc><news:news><news:publication><news:name>Humpleby &amp; Strauss Mesothelioma News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T10:45:00-05:00</news:publication_date><news:title>New Mesothelioma Study Finds That Delayed Referrals and Limited Specialist Access Can Affect Treatment Choices</news:title></news:news></url>
  <url><loc>https://humplebystrauss.com/news/mesothelioma-immunotherapy-hospitalizations-side-effects-november-2026</loc><news:news><news:publication><news:name>Humpleby &amp; Strauss Mesothelioma News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-17T10:00:00-05:00</news:publication_date><news:title>Mesothelioma Immunotherapy Study Highlights Hospitalizations and the Importance of Recognizing Side Effects</news:title></news:news></url>
  <url><loc>https://humplebystrauss.com/news/mesothelioma-chemotherapy-resistance-ccl5-ccr5-november-2026</loc><news:news><news:publication><news:name>Humpleby &amp; Strauss Mesothelioma News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-16T13:00:00-05:00</news:publication_date><news:title>Why Mesothelioma Can Stop Responding to Chemotherapy: New Study Examines How Tumors Influence Immune Cells</news:title></news:news></url>
</urlset>
